Episodes

Chapter 2 of a 2-Part CE Podcast This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/. As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated...

Chapter 1 of a 2-Part CE Podcast This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/multiple-myeloma-decision-tool/. As MM progresses to relapsed/refractory MM (RRMM), the selection of an appropriate treatment regimen becomes more complex, requiring an assessment of severity, risk, and prior lines of therapy. Newer agents such as chimeric antigen receptor (CAR) T-cell therapies or bispecific antibody therapies may be indicated...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/sclc-evolving-treatment-landscape. This activity will provide managed care professionals with a practical, evidence-based review of the evolving treatment landscape in extensive-stage small cell lung cancer (ES-SCLC), with a focus on how emerging clinical data can inform coverage policies, oncology pathways, and utilization management strategies. Participants will explore the ...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/clearer-pathways. Given emerging evidence and recently updated clinical guidelines in the management of retinal diseases, managed care and payer professionals require competence to integrate emerging clinical trends and updates into the management of retinal diseases. There is a growing need for health care professionals to understand evidence-based care management strate...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/psoriasis-best-practices/. The psoriasis treatment landscape is rapidly evolving. Although treatment guidelines are routinely updated, ongoing innovation and the introduction of new therapies frequently render even the most current guidelines incomplete. During this podcast, managed care decision makers will expand their knowledge and learn about the importance of early interv...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://managedcareeye.com/preventing-blindness. This podcast will highlight challenges across the patient journey—including access to care, benefit design, and coverage decision-making—and their impact on timely diagnosis and treatment. The expert faculty will share payer perspectives on current coverage policies, care coordination, and system-level opportunities to support earlier intervention and ev...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mg-management. Managed care professionals face unique challenges in optimizing outcomes for patients with MG, a rare, chronic autoimmune neuromuscular disorder characterized by fluctuating muscle weakness and fatigue. The increasing prevalence and complexity of MG, combined with rapid advances in targeted therapies, require updated knowledge and strategic approaches to coverag...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/bridging-the-gaps/. This podcast will examine how payer policies shape the real world management of diabetic retinopathy (DR), diabetic macular edema (DME), and age related macular degeneration (AMD), highlighting health care provider insights on the systemic challenges that affect patient access, treatment consistency, and outcomes. Discussion will center on coverage rel...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/asthma-management-best-practices/. Asthma remains a major public health issue in the US, with many patients still uncontrolled despite available treatments and evidence-based guidelines. This leads to preventable ER visits, hospitalizations, and significant costs—over $80 billion annually. The NCQA has updated HEDIS® for 2026 to include a new measure, Follow-Up After Acute and...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.managedcareeye.com/aligning-policy-with-practice/. Within the space of just a few years, several new retinal treatments have been approved promising increased durability and better patient outcomes. These conditions can significantly impact vision and quality of life for patients. This webcast will explore how clinical realities intersect with coverage policies in the management of diabetic...

This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/hypertrophic-cardiomyopathy-payertalkce/. Through a multidisciplinary discussion format, the podcast will address critical gaps in payer understanding of hypertrophic cardiomyopathy (HCM), including guideline interpretation, coverage implications, emerging pharmacologic options such as cardiac myosin inhibitors, and the importance of shared decision‑making to support individua...